HB 443 (2017): prohibiting prescription drug manufacturers from offering copayment reimbursement.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 443 (2017): prohibiting prescription drug manufacturers from offering copayment reimbursement.” Granite Record, https://graniterecord.org/bill/2017/hb443. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 443 (2017): prohibiting prescription drug manufacturers from offering copayment reimbursement. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2017/hb443
- Chicago
- Granite Record. “HB 443 (2017): prohibiting prescription drug manufacturers from offering copayment reimbursement.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2017/hb443.
- BibTeX
@misc{bill-2017-hb443, title = {HB 443 (2017): prohibiting prescription drug manufacturers from offering copayment reimbursement.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2017/hb443}, note = {Accessed 24 Oct. 2026} }
HB 443 (2017)
prohibiting prescription drug manufacturers from offering copayment reimbursement.
- Status: Killed
- Term: 2017-2018
- House committee: Commerce and Consumer Affairs
- Subject: Miscellaneous
The Story
It was introduced on January 5, 2017 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on January 24, 2017. The committee held a work session on February 1, 2017. The committee met in executive session on February 21, 2017 to vote on its recommendation. The committee voted unanimously, 18–0, to recommend that the House kill it, and the report was placed on the consent calendar. On March 8, 2017 the House voted to kill it on a voice vote.
Sponsors
- Rep. Neal Kurk (R - Hills 2) (prime sponsor)
- Rep. William Marsh (D - Carr 8)
Hearings and Sessions
- January 24, 2017, 1:15 PM: public hearing, House Commerce and Consumer Affairs, LOB 302
- February 1, 2017, 9:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 303
- February 21, 2017, 1:30 PM: executive session, House Commerce and Consumer Affairs, LOB 302
Votes
- March 8, 2017, House: Inexpedient to Legislate — voice vote, passed
The Docket
- January 5, 2017: Introduced 01/05/2017 and referred to Commerce and Consumer Affairs
- January 24, 2017: Public Hearing: 01/24/2017 01:15 PM LOB 302
- February 1, 2017: Subcommittee Work Session: 02/01/2017 09:00 AM LOB 303
- February 21, 2017: Executive Session: 02/21/2017 01:30 PM LOB 302
- March 8, 2017: Committee Report: Inexpedient to Legislate for 03/08/2017 (Vote 18-0; CC)
- March 8, 2017: Inexpedient to Legislate: MA VV 03/08/2017